Abstract
Clinics and pathology Disease NHL of the low to intermediate grade. Phenotype / cell stem origin B-cell lineage. Epidemiology 5% of NHL; sex ratio: 3M/1F; median age: 65 yrs. Clinics Advanced disease (Ann Harbor stage III-IV) with generalized lymphadenopathies in 90%, bone marrow involvement (70%), frequent splenomegaly (50%), hepatomegaly (30%), and gastro-intestinal involvement (20%), and lymphocytosis (30%); elevated LDH in 50%. Pathology Small cleaved cell B-lymphocytes with inconspicuous nucleoli and pale cytoplasm; with a pan B-cell, CD5+, CD10-, CD23(in contrast with CLL) phenotype; diffuse, nodular and blastoid types, the latter having large cells and higher mitotic count.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Atlas of Genetics and Cytogenetics in Oncology and Haematology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
